CLINICAL TRIALS PROFILE FOR IDALOPIRDINE
✉ Email this page to a colleague
Clinical Trials for Idalopirdine
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT01955161 ↗ | Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil | Completed | Otsuka Pharmaceutical Co., Ltd. | Phase 3 | To establish efficacy of idalopirdine as adjunctive therapy to donepezil for symptomatic treatment of patients with mild-to-moderate Alzheimer's disease (AD). |
NCT01955161 ↗ | Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil | Completed | H. Lundbeck A/S | Phase 3 | To establish efficacy of idalopirdine as adjunctive therapy to donepezil for symptomatic treatment of patients with mild-to-moderate Alzheimer's disease (AD). |
NCT02006641 ↗ | Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil | Completed | Otsuka Pharmaceutical Co., Ltd. | Phase 3 | To establish efficacy of Idalopirdine as adjunctive therapy to donepezil for symptomatic treatment of patients with mild-to-moderate Alzheimer's disease (AD). |
NCT02006641 ↗ | Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil | Completed | H. Lundbeck A/S | Phase 3 | To establish efficacy of Idalopirdine as adjunctive therapy to donepezil for symptomatic treatment of patients with mild-to-moderate Alzheimer's disease (AD). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Idalopirdine
Condition Name
Clinical Trial Locations for Idalopirdine
Trials by Country
Clinical Trial Progress for Idalopirdine
Clinical Trial Phase
Clinical Trial Sponsors for Idalopirdine
Sponsor Name